Crypto News

Apr 20, 2026

Theriva Biologics (TOVX) Stock Soars 63% on Promising Pancreatic Cancer Trial Results

Stocks

Theriva Biologics (TOVX) stock surged 63% after Phase 2b trial data revealed VCN-01 plus chemo improved survival in metastatic pancreatic cancer patients.

The post Theriva Biologics (TOVX) Stock Soars 63% on Promising Pancreatic Cancer Trial Results appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$BHYP$BMNR$JENNER Token$RKC$USOR13F Filing1INCH1inch200-Week MA200-day moving average200ma21Shares21shares Hyperliquid21shares Hyperliquid ETF401k50 week MA@CryptoCupra@SherlockwhalesA7A5AAVE Bearish

Latest News